Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug Interaction
NCT04396730 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2023-07-11
Summary
The purpose of this study is to assess how Cannabidiol (CBD) impacts the effectiveness of oral contraceptive (birth control) pills and if CBD changes the possible side effects of birth control pills when CBD and birth control pills are taken at the same time.
This study explores the potential interaction between CBD and birth control pills by assessing serum levels of the contraceptive steroid hormones ethinyl estradiol and levonorgestrel in birth control pill users when they also use CBD.
Conditions
- Contraception
Interventions
- DRUG
-
Cannabidiol Oil
400 mg Cannabidiol oil will be administered daily along with oral contraceptives daily for 24 days.
- DRUG
-
Placebo will be administered daily along with oral contraceptives daily for 24 days.
- DRUG
-
Combined oral contraceptive pill
All participants will receive oral contraceptives
Sponsors & Collaborators
- collaborator OTHER
-
Oregon Health and Science University
lead OTHER
Principal Investigators
-
Shaalini Ramanadhan, MD · Oregon Health and Science University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-04-08
- Primary Completion
- 2022-03-02
- Completion
- 2022-03-02
Countries
- United States
Study Locations
More Related Trials
-
Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects
NCT04309643 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914
NCT00791297 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00477633 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women
NCT01953809 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Single Group Study to Evaluate the Effects of a Topical Product on Cramps Associated With the Menstrual Cycle
NCT06939972 ·Status: COMPLETED ·Phase: NA
-
Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants
NCT02027337 ·Status: UNKNOWN ·Phase: PHASE4
-
Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales
NCT02210702 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Oral Contraceptives on GABA and Neurosteroids
NCT00656318 ·Status: TERMINATED
-
The Effect of Hormonal Contraception on Female
NCT01852786 ·Status: UNKNOWN
-
A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers
NCT01714193 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Contraceptive Consumption Timing and Cognition and Metabolism
NCT06560944 ·Status: COMPLETED ·Phase: NA
-
CP-690,550 And Oral Contraception Drug-Drug Interaction Study
NCT01137708 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00391807 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives
NCT00089414 ·Status: TERMINATED ·Phase: PHASE2
-
How DHEA Supplements Affect Coagulation in Women Using Birth Control Pills
NCT03418363 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Contraceptives and Economic Behaviour
NCT02257671 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function
NCT00128726 ·Status: COMPLETED
-
Study of Bleeding With Extended Administration of an Oral Contraceptive
NCT00338052 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants
NCT04718636 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Measuring the Effectiveness of BMS-986256 Combined With Oral Contraceptive in Healthy Female Participants
NCT04016753 ·Status: COMPLETED ·Phase: PHASE1
-
Hormonal Contraception and Risk of Chlamydia and Gonorrhea
NCT00091728 ·Status: TERMINATED
-
Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects
NCT00983957 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential
NCT04934696 ·Status: COMPLETED ·Phase: PHASE1
-
Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.
NCT01251263 ·Status: UNKNOWN ·Phase: PHASE4
-
Quality of Life During Different Regimens of Combined Hormonal Contraceptives in Women of Reproductive Age
NCT06918873 ·Status: RECRUITING